Pharmaceuticals

Rising Heart Attack Cases Fueling The Growth Of The Market Due To Demand For Rapid-Acting Emergency Medications Is Supporting Development Across The Fast Melt Tablets Market

May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Fast Melt Tablets Market Through 2030?

The fast melt tablets market has experienced robust growth recently. This market is projected to expand from $5.33 billion in 2025 to $5.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.8%. Historically, this expansion has been linked to factors such as the challenge of swallowing traditional tablets, increasing numbers of pediatric and geriatric individuals, prompt utilization in allergy and CNS medications, a need for quick-acting formulations, and the proliferation of over-the-counter (OTC) fast-dissolving medicines.

The fast melt tablets market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $7.73 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. Key factors driving this growth during the forecast period include a heightened emphasis on patient compliance, an increase in neurological and psychiatric disorders, the need for user-friendly drug delivery methods, the broadening scope of homecare medication application, and advancements in oral thin-film technologies. Significant trends emerging within the forecast timeframe involve a growing preference for patient-friendly oral dosage forms, greater utilization in medications for pediatric and geriatric populations, broader application in CNS and pain management, an increasing inclination towards water-free drug administration, and more widespread integration into travel-friendly and emergency medical scenarios.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Which Growth Factors Are Strengthening The Fast Melt Tablets Market Landscape?

An increasing occurrence of heart attacks is anticipated to drive the expansion of the fast melt tablets market in the future. A heart attack constitutes a medical crisis where blood supply to the heart muscle is obstructed, typically by a blood clot or an accumulation of plaque within the coronary arteries. The frequency of heart attacks is escalating, primarily attributed to greater intake of processed foods, resulting in elevated cholesterol and the formation of arterial plaque. Rapid drug absorption is offered by fast melt tablets, facilitating faster administration of vital medicines like aspirin or nitroglycerin. This aids in preventing additional harm during a heart attack, thereby enhancing patient results by re-establishing blood flow and lessening the likelihood of serious complications. As an illustration, in September 2025, the British Heart Foundation, a cardiovascular research charity based in the UK, projected an increase of one million individuals living with cardiovascular disease in the UK by 2030, further escalating to two million more than current figures by 2040. This represents the highest figure ever recorded. Consequently, the increasing prevalence of heart attacks is fueling the expansion of the fast melt tablets market.

What Segment Categories Are Evaluated In The Fast Melt Tablets Market Study?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil

4) By Anxiolytics: Benzodiazepines, Azapirones, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Analgesics

What Trends Are Affecting The Growth Of The Fast Melt Tablets Market?

Major companies operating in the fast melt tablets market are prioritizing formulation innovation, specifically orally disintegrating tablet (ODT) technologies, which enable rapid dissolution without water, to improve medication adherence, convenience, and accessibility for patients with chronic neurological conditions. Orally Disintegrating Tablet (ODT) Technology delivers active ingredients in a fast-melt format that disintegrates on the tongue within seconds, offering ease of administration for patients who have difficulty swallowing traditional tablets or need discreet, portable dosing alternatives. For instance, in February 2023, Cycle Pharmaceuticals Ltd., a U.K.-based rare disease and specialty pharmaceuticals company, launched TASCENSO ODT (fingolimod), the first FDA-approved orally disintegrating tablet for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 years and older. Developed utilizing Catalent’s ZYDIS fast-dissolve platform, this bioequivalent non-generic ODT ensures continuity of care for U.S. patients losing access to Gilenya support services and is supported by Cycle’s dedicated patient platform, Cycle Vita, providing co-pay assistance, bridge programs, and in-home baseline assessments to maintain uninterrupted fingolimod therapy.

Who Are The Businesses Driving Activity In The Fast Melt Tablets Market?

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Lannett Company Inc., Perrigo Company plc, Catalent Inc., SPI Pharma Inc., Fuji Chemical Industries Co. Ltd., Melt Pharmaceuticals Inc., Akina Inc., Church & Dwight Co. Inc., Windmill Health Products LLC, The Procter & Gamble Company, Hikma Pharmaceuticals plc, Dr. Reddy’s Laboratories Ltd.

Access The Complete Fast Melt Tablets Market Report:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

Which Region Commands The Largest Share Of The Fast Melt Tablets Market?

North America was the largest region in the fast melt tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Fast Melt Tablets Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Browse Through More Reports Similar to the Global Fast Melt Tablets Market 2026, By The Business Research Company

Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Effervescent Tablet Market Report 2026

https://www.thebusinessresearchcompany.com/report/effervescent-tablet-global-market-report

Hot Melt Based Adhesives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hot-melt-based-adhesives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795